Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Serán Bioscience is a contract development and manufacturing organization.
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
CereVasc is a medical device company that develops a minimally invasive treatment option for communicating hydrocephalus.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Bain Capital Life Sciences has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Bain Capital Life Sciences's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics. The firm invests across 17 different industry categories.
Among tracked funding rounds, New Amsterdam Pharma received $452.6M in a Post-IPO Equity round. Bain Capital Life Sciences's total known invested capital is $9.0B.
Bain Capital Life Sciences's average investment size is $163.2M across its portfolio of 57 companies.
Recent Bain Capital Life Sciences portfolio additions include Serán Bioscience, Amylyx Pharmaceuticals, Cardurion Pharmaceuticals, AdvanCell, Upstream Bio. These companies were founded in 2020 or later.